Highlights Enzolytics, Inc.

Equities

ENZC

US2941121079

Market Closed - OTC Markets Other stock markets 03:49:16 2024-07-08 pm EDT			5-day change	1st Jan Change
0.0018 ^USD	+2.86%		-5.26%	-89.71%

May. 02	Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment LLC	CI
Mar. 25	Enzolytics, Inc. Announces Board Changes	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Enzolytics, Inc. Announces Formation of Marketing Company in Partnership with Third Coast Fulfillment LLC	May. 02	CI
Enzolytics Offers Update on Virogentics, Inc ITV-1 African Project	23-06-26	CI
Enzolytics, Inc. Provides Update on Clinical Trials	23-04-21	CI
Biogenysis, Inc. & Virogentics, Inc. executed a non-binding term sheet to acquire Sagaliam Acquisition Corp. from Lighthouse Investment Partners, LLC, Enzolytics, Inc., Sagaliam Sponsor LLC, GLD Sponsor Member, LLC, AHG Equities LLC and others for $450 million in a reverse merger transaction.	23-04-16	CI
Enzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in Africa	23-02-08	CI
Enzolytics to Develop Feline Monoclonal Antibodies	23-01-03	CI
Enzolytics, Inc. Announces U.S. Distribution of IPF Immune(TM) and Progress in each of its Therapeutic Platforms	22-12-13	CI
Enzolytics, Inc. Announces Expansion of Production of Its Monoclonal Antibody Therapeutics and Marketing of IPF Immune	22-11-16	CI
Enzolytics Inc. Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology Study	22-10-05	CI
Enzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal Antibodies	22-09-16	CI
Enzolytics Inc. and Samsung Biologics Co., Ltd. Announce Development and Manufacturing Agreement	21-10-07	CI
Enzolytics Inc. completed the acquisition of BioClonetics Immunotherapeutics, Inc.	20-11-30	CI
Enzolytics Inc. executed a non-binding letter of intent to acquire BioClonetics Immunotherapeutics, Inc.	20-09-15	CI
Eco Petroleum Solutions, Inc. Announces Exclusive Distribution Agreement with IMMB BG	17-06-22	CI
Eco-Petroleum Solutions, Inc. acquired Immunotech Laboratories, Inc..	17-06-13	CI
Eco Petroleum Solutions, Inc. Announces Establishment of New Subsidiary Petrogistics, Inc	15-02-23	CI
Eco-Petroleum Solutions, Inc. acquired Bottle Brands of Dolton in Illinois.	15-01-18	CI
Structural Enhancement Technologies Corp cancelled the acquisition of bottling facility in Bedford Park, Illinois.	13-06-22	CI
Challenger Brands Corp. cancelled the acquisition of Structural Enhancement Technologies Corp in a reverse merger transaction.	13-06-06	CI
Structural Enhancement Technologies Corp entered into an agreement to acquire a bottling facility in Bedford Park, Illinois.	12-06-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Enzolytics, Inc.

Equities

ENZC

US2941121079

Highlights

Filters